Hexicon, vaginal tablets 16 mg 10 pcs

Pharmacodynamics

Topical antiseptic agent with predominantly bactericidal action against Gram-positive and Gram-negative bacteria, has fungicidal and virucidal action (against lipophilic viruses).

It is active against protozoa, Gram-positive and Gram-negative bacteria, viruses including Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Trichomonas vaginalis, Gardnerella vaginalis, Bacteroides fragilis, Herpes simplex 2 type.

Some strains of Pseudomonas spp., Proteus spp. are weakly sensitive to the drug, as well as acid-resistant forms of bacteria, bacterial spores. Chlorhexidine does not impair the functional activity of lactobacilli. Maintains activity (although somewhat reduced) in the presence of blood, pus.

Pharmacokinetics

Systemic absorption during intravaginal use is insignificant.

Indications

Treatment of bacterial vaginosis, colpitis (including nonspecific, mixed, trichomonas).
Prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth and abortion, before and after installation of an intrauterine device (IUD), before and after diathermocoagulation of the cervix, before intrauterine examinations).
Prevention of sexually transmitted infections (chlamydia, ureaplasmosis, trichomoniasis, gonorrhea, syphilis, genital herpes) – use no later than 2 hours after sexual intercourse.

Pharmacological effect

Pharmacodynamics

A local antiseptic with a predominantly bactericidal effect against gram-positive and gram-negative bacteria, and has a fungicidal and virucidal effect (against lipophilic viruses).

Active against protozoa, gram-positive and gram-negative bacteria, viruses, including Treponema pallidum, Chlamydia spp., Ureaplasma spp., Neisseria gonorrhoeae, Trichomonas vaginalis, Gardnerella vaginalis, Bacteroides fragilis, Herpes simplex type 2.

Some strains of Pseudomonas spp., Proteus spp. are weakly sensitive to the drug, and acid-resistant forms of bacteria and bacterial spores are also resistant. Chlorhexidine does not interfere with the functional activity of lactobacilli. Remains active (albeit somewhat reduced) in the presence of blood and pus.

Pharmacokinetics

Systemic absorption after intravaginal use is negligible.

Special instructions

Toilet of the external genitalia does not affect the effectiveness and tolerability of Hexicon® vaginal tablets, since the drug is used intravaginally.

It can be used during menstruation, since Hexicon® tablets retain their activity, although somewhat reduced, in the presence of blood, pus and other biological fluids.

Active ingredient

Chlorhexidine

Composition

One tablet contains:
active ingredient – chlorhexidine bigluconate – 16.0 mg (in the form of chlorhexidine bigluconate solution 20% – 85.2 mg);
excipients: microcrystalline cellulose, pregelatinized corn starch, povidone K 17, stearic acid, lactose monohydrate.

Contraindications

Hypersensitivity to the components of the drug.

With caution

Childhood.

In childhood, it is recommended to use Hexicon® D, vaginal suppositories 8 mg.

Side Effects

Allergic reactions and vaginal itching are possible, which disappear after discontinuation of the drug.

Interaction

Hexicon is not compatible with detergents containing an anionic group (saponins, sodium lauryl sulfate, sodium carboxymethylcellulose) and soaps.

The presence of soap can inactivate chlorhexidine, so before using the drug, any remaining soap must be thoroughly rinsed off.

Prescribing

Antiseptic

Complete set of goods

Vaginal tablets 16 mg.

5 or 10 tablets in a blister pack made of polyvinyl chloride film and printed varnished aluminum foil.

1, 2 blister packs of 5 tablets each or 1 blister pack of 10 tablets, together with instructions for medical use of the drug, are placed in a cardboard pack.

Functional features

Systemic absorption after intravaginal use is negligible.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 ° C.

Keep out of the reach of children.

Shelf life

2 years. Do not use the drug after the expiration date indicated on the package.

Manufacturer

Hemofarm LLC, Russia